Republicans block cap on patient insulin costs
GOP lawmakers had earlier tried to offer their own, more scaled-back version of an insulin price limit, but Democrats rejected it as too narrow.
Eli Lilly and Co.
Articles
In wake of new abortion ban, Lilly says it will look outside Indiana for expansion projects
Indianapolis-based Eli Lilly and Co. said Indiana’s new abortion law could hinder its ability to attract diverse scientific, engineering and business talent to the state.
Jury orders Lilly to pay $61M in whistleblower Medicaid fraud case
The cost to Indianapolis-based Eli Lilly and Co. would reach more than $183 million because cases brought under the False Claims Act triple the final judgment. Lilly said it plans to appeal and is confident that it will prevail.
Lilly Q2 profit slumps 33% as older products lose steam
Indianapolis-based Eli Lilly and Co. posted a profit of $1.13 billion, down from $1.68 billion a year ago, and cut its full-year profit guidance.
Lilly Endowment sells more than $500 million in Eli Lilly stock
The stock sale is a primary way for the endowment, one of the largest private philanthropic foundations in the United States, to raise cash to make grants to arts, education, religious and community development organizations.
Lilly overtakes larger rival Pfizer in market cap as shares continue to soar
Like a kite that has caught a stiff breeze, Eli Lilly and Co. stock is having the ride of its life. Shares in the Indianapolis-based drugmaker have soared 41% in the past 52 weeks, to about $331 each.
Lilly inks $275M deal to supply more COVID-19 antibody
Indianapolis-based Eli Lilly and Co. on Wednesday announced an agreement with the U.S. government to supply an additional 150,000 doses of its COVID-fighting antibody bebtelovimab.
Lilly faces lawsuit over alleged excessive retirement-plan fees
The drugmaker is one of hundreds of U.S. companies being sued in the recent trend in litigation: excessive fees on 401(k) retirement plans.
Lilly whistleblower sues drugmaker, alleging retaliation
A top human resources officer at Eli Lilly and Co.’s factory in New Jersey claims the drugmaker fired her in retaliation for investigating employee complaints about drug manufacturing problems and for refusing to drop the matter.
Boone County officials tout Lilly’s $2.1B manufacturing plan as a ‘game-changer’
Lebanon Mayor Matt Gentry called Eli Lilly’s plans to build two pharmaceutical manufacturing sites “transformational” for his city.
Lilly to anchor state’s new innovation district with $2.1B in manufacturing facilities
The Indianapolis-based drugmaker said Wednesday the project in Boone County will create up to 500 jobs in central Indiana, along with up to 1,500 temporary construction jobs.
FDA approves Lilly diabetes drug that helps patients lose weight
The drug has been closely watched by medical professionals and is viewed by financial analysts as a possible blockbuster, with potential annual sales in the billions of dollars.
Lilly CEO has leaders talking about whether state is doing enough to grow Indiana
David Ricks’ lunchtime speech to The Economic Club of Indiana—repeated on social media by those in attendance and reported by IBJ and local TV stations—has reverberated across the state.
Lilly’s David Ricks: ‘We’re going to struggle’
The following is a partial transcript of Ricks’ speech to the Economic Club of Indiana on April 20, in which he spoke about problems in Indiana’s business climate.
Lilly profit soars 40% in first quarter
Eli Lilly and Co. posted profit of $1.9 billion in the first quarter, up 40%, on higher sales of COVID-19 antibodies and other key products for diabetes, cancer and arthritis.
Lilly says experimental drug helped patients lose up to 22% of body weight
The drug, called tirzepatide, has been closely watched by medical professionals and is viewed by financial analysts as possible blockbuster, with potential annual sales in the billions of dollars.
Lilly CEO: Indiana must improve education, reduce health care costs to stay competitive
When it comes to competing for jobs, Indiana is far behind the curve in critical ways, Eli Lilly and Co. CEO David Ricks told a lunch crowd Wednesday at the Economic Club of Indiana.
Lilly says it will push ahead on Alzheimer’s drug
The push by Eli Lilly and Co. will come despite an unfavorable ruling last week from Medicare that sharply restricts reimbursements for a drug in the same class.
As Lilly stock surges, endowment prepares to give away more cash
Since early March, the Lilly Endowment has sold 1.3 million shares of Eli Lilly and Co. stock, raising $391 million, according to government filings.
House passes $35-a-month insulin cap as Dems seek wider bill
The Affordable Insulin Now Act will serve as a political vehicle to rally Democrats and force Republicans who oppose it into uncomfortable votes ahead of the midterms.